Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Craigavon-based Almac Pharma is set to expand its commercial manufacturing over the next three years, following the completion of a new non-GMP drug development facility.
Subscribe to our email newsletter
Reinforcing its Northern Ireland’s position in the wider life sciences sector, the dual expansion represents a total investment of £13.7m with some financial assistance from Invest Northern Ireland.
Enterprise minister Arlene Foster said the investment will result in the creation of 229 new jobs that will bring a positive economic boost.
"Almac has a reputation for excellence in the international pharmaceuticals sector and today’s announcement will ensure that it remains in a competitive position and can continue to meet the needs of its global client base," Foster added.
The new 13,400ft2 formulation development facility and analytical laboratories are being built for the development of tablet and capsule formulations for new drugs which are in the early stages of development and are yet to be marketed.
The investment will deliver blending equipment, an automated packing and integrated cartoning line to enable high volume bulk commercial manufacturing, which is scheduled to begin in November 2013.